Alkermes
inhibition of growth factor pathways induces immunogenic cancer cell death combination with growth factor pathway inhibitors growth factor pathway inhibitors anti growth factor receptors immune cell trafficking to tumor tissue activity of immune suppressive cells tumor cell survival growth tumor cell metastasis tumor angiogenesis growth factors support several mechanisms that promote cancer cell survival and metastasis inhibition of tumor growth factor pathways is a validated therapeutic approach in oncology cell mediated immune responses emerging from inhibition of tumor growth factors may be augmented by ability to activate cancer fighting immune cells immunogenic cancer cell death release of cancer antigens cell activation and expansion cancer metastasis rev physiology oncology mechanism of inhibitor action accessed march ref | Alkermes
Company
Deck Type
Deck date
March 2021
Slide
92 of 144
Related slides by other companies
Investor Day
December 2021
Investor Presentation
November 2023
Investor Presentation
January 2024
Investor Presentation
February 2024
Other recent decks by Alkermes
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io